Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa.
Reid, Stewart E
Fox, Matthew P
AffiliationInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. firstname.lastname@example.org
MetadataShow full item record
AbstractTo investigate the incidence of selected opportunistic infections (OIs) and cancers and the role of a history of tuberculosis (TB) as a risk factor for developing these conditions in HIV-infected patients starting antiretroviral treatment (ART) in Southern Africa.
- The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
- Authors: Ives NJ, Gazzard BG, Easterbrook PJ
- Issue date: 2001 Feb
- The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
- Authors: Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ
- Issue date: 2009 Jul
- Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
- Authors: Lawn SD, Myer L, Edwards D, Bekker LG, Wood R
- Issue date: 2009 Aug 24
- Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.
- Authors: Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KT, Kuritzkes DR, Smeaton L
- Issue date: 2010 Jul
- Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
- Authors: Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, Santos J, Wells C, Paine P, Garrett D
- Issue date: 2007 Sep 5